.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
Boehringer Ingelheim
Chubb
McKesson
Accenture
UBS
Novartis
Moodys
Farmers Insurance

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200673

« Back to Dashboard
NDA 200673 describes CLONIDINE HYDROCHLORIDE, which is a drug marketed by Hikma Farmaceutica, Zydus Pharms Usa Inc, Duramed Pharms Barr, Prinston Inc, Teva, Luitpold, Mylan, Actavis Elizabeth, Frontida Biopharm, Sun Pharm Inds Inc, Warner Chilcott, Interpharm, Par Pharm, Watson Labs, Exela Pharma Scs Llc, Alembic Pharms Ltd, Fresenius Kabi Usa, Am Therap, Anchen Pharms, Chartwell Molecules, Aurolife Pharma Llc, Unichem, Yung Shin Pharm, and Impax Labs, and is included in fifty-three NDAs. It is available from fifty-seven suppliers. Additional details are available on the CLONIDINE HYDROCHLORIDE profile page.

The generic ingredient in CLONIDINE HYDROCHLORIDE is chlorthalidone; clonidine hydrochloride. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.

Summary for 200673

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 200673

Mechanism of ActionAdrenergic alpha2-Agonists

Suppliers and Packaging for NDA: 200673

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
INJECTABLE;INJECTION 200673 ANDA Fresenius Kabi USA, LLC 63323-405 63323-405-10 1 VIAL in 1 CARTON (63323-405-10) > 10 mL in 1 VIAL
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
INJECTABLE;INJECTION 200673 ANDA Fresenius Kabi USA, LLC 63323-427 63323-427-10 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-427-10) > 10 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/10ML (0.1MG/ML)
Approval Date:Jul 8, 2011TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5MG/10ML (0.5MG/ML)
Approval Date:Jul 8, 2011TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
QuintilesIMS
Farmers Insurance
Chubb
Cipla
AstraZeneca
Novartis
Express Scripts
Accenture
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot